Skip to main content

Advertisement

Open Peer Review Reports for: S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
27 May 2014 Submitted Original manuscript
7 Jun 2014 Author responded Author comments - Young Park
Resubmission - Version 2
7 Jun 2014 Submitted Manuscript version 2
9 Jul 2014 Reviewed Reviewer Report - Young-Woong Won
11 Jul 2014 Reviewed Reviewer Report - Jung Hun kang
Resubmission - Version 3
Submitted Manuscript version 3
20 Aug 2014 Author responded Author comments - Young Park
Resubmission - Version 4
20 Aug 2014 Submitted Manuscript version 4
27 Sep 2014 Reviewed Reviewer Report - Jung Hun kang
11 Oct 2014 Author responded Author comments - Young Park
Resubmission - Version 5
11 Oct 2014 Submitted Manuscript version 5
23 Oct 2014 Author responded Author comments - Young Park
Resubmission - Version 6
23 Oct 2014 Submitted Manuscript version 6
29 Oct 2014 Author responded Author comments - Young Park
Resubmission - Version 7
29 Oct 2014 Submitted Manuscript version 7
10 Nov 2014 Author responded Author comments - Young Park
Resubmission - Version 8
10 Nov 2014 Submitted Manuscript version 8
Publishing
18 Nov 2014 Editorially accepted
26 Nov 2014 Article published 10.1186/1471-2407-14-883

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement